Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Results from a pilot study for large-scale plasma procurement using automated plasmapheresis showed that it could safely and economically produce high-quality plasma, necessary for national self-sufficiency.

  • Read more about Results from a pilot study for large-scale plasma procurement using automated plasmapheresis showed that it could safely and economically produce high-quality plasma, necessary for national self-sufficiency.

In a written parliamentary answer, Kenneth Clarke, Minister of State for Health, stated that the Government decided in 1982 that self-sufficiency in all blood products should be achieved and the BPL at Elstree should be rebuilt to provide capacity to manufacture blood products needed by the NHS in England and Wales. It was said to be on time for completion in January 1986.

  • Read more about In a written parliamentary answer, Kenneth Clarke, Minister of State for Health, stated that the Government decided in 1982 that self-sufficiency in all blood products should be achieved and the BPL at Elstree should be rebuilt to provide capacity to manufacture blood products needed by the NHS in England and Wales. It was said to be on time for completion in January 1986.

Manual plasmapheresis started to fall out of favour compared to machine plasmapheresis. The Mersey Regional BTS opted against manual plasmapheresis due to problems associated with the need for a continuous supervisor, the time needed to complete a procedure and the need for temperature-controlled centrifuges. This was despite the use of machines.

  • Read more about Manual plasmapheresis started to fall out of favour compared to machine plasmapheresis. The Mersey Regional BTS opted against manual plasmapheresis due to problems associated with the need for a continuous supervisor, the time needed to complete a procedure and the need for temperature-controlled centrifuges. This was despite the use of machines.

A lack of ministerial decision, ministerial uncertainty, and the absence of long-term management arrangements were issues identified by Mr Smart as hampering the work done by the Policy Steering Group for the re-development of BPL.

  • Read more about A lack of ministerial decision, ministerial uncertainty, and the absence of long-term management arrangements were issues identified by Mr Smart as hampering the work done by the Policy Steering Group for the re-development of BPL.

No existing factory building could be found to accommodate BPL, even with adaptations.

  • Read more about No existing factory building could be found to accommodate BPL, even with adaptations.

A pilot study conducted by Dr Robinson's team using the new Haemonetics v50 machine became a turning point in the UK, showing it enabled plasmapheresis more efficiently and more safely.

  • Read more about A pilot study conducted by Dr Robinson's team using the new Haemonetics v50 machine became a turning point in the UK, showing it enabled plasmapheresis more efficiently and more safely.

Dr Waiter stated that it was accepted that in order to meet the anticipated demand for principal plasma fractions, a new plant in addition to that already available in the UK must be acquired.

  • Read more about Dr Waiter stated that it was accepted that in order to meet the anticipated demand for principal plasma fractions, a new plant in addition to that already available in the UK must be acquired.

Thomas Dutton observed that the Development of the NBTS Trends Report essentially said no more about Factor 8 requirements than some experts had been saying for years, which had now become generally accepted.

  • Read more about Thomas Dutton observed that the Development of the NBTS Trends Report essentially said no more about Factor 8 requirements than some experts had been saying for years, which had now become generally accepted.

The 1975 target of 350,000 donor units was met, but Thomas Dutton stated that this target had long since been recognised as too low.

  • Read more about The 1975 target of 350,000 donor units was met, but Thomas Dutton stated that this target had long since been recognised as too low.

Thomas Dutton stated that devising and effectively managing a balanced programme for the preparation and distribution of blood components including clotting factors as "probably the most urgent task facing the NBTS" and he spoke of the need to fractionate something approaching one million donations annually.

  • Read more about Thomas Dutton stated that devising and effectively managing a balanced programme for the preparation and distribution of blood components including clotting factors as "probably the most urgent task facing the NBTS" and he spoke of the need to fractionate something approaching one million donations annually.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 288
  • Page 289
  • Page 290
  • Page 291
  • Current page 292
  • Page 293
  • Page 294
  • Page 295
  • Page 296
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.